Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, and Enzymatic), By Modality (Wearable, Non-Wearable/Benchtop, and Embedded Devices), By End User (Hospitals, Clinics, and Homecare Setting), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Feb 2024

Code : CMI1480

Pages :163

Formats :

Excel and PDF

Industry : Medical Devices

Non-Invasive Blood Glucose Monitoring Devices MarketSize and Trends

The global non-invasive blood glucose monitoring devices market was valued US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031 growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.

Global Non-Invasive Blood Glucose Monitoring Devices Market Trends

Transition towards continuous glucose monitoring solutions: The transition towards continuous glucose monitoring solutions is having a significant influence on non-invasive blood glucose monitoring device market. Continuous glucose monitors which track glucose levels in real time and alert patients to high or low readings are becoming more widely adopted compared to conventional self-monitoring practices of finger pricks. Continuous glucose monitoring (CGM) devices are becoming gradually used by individuals with diabetes to as offer a snapshot of glucose concentration at the time of testing and help control their condition. For instance, according to Royal Society of Chemistry, publication ‘Recent advances in optical sensors for continuous glucose monitoring’ in July 2022, measuring blood glucose levels during physical activity is of utmost importance as the measurement of hypo and hyperglycemia during and after the physical activities as it can affect patient health. Continuous Glucose Monitoring (CGM) is vital for diabetic individuals to maintain a healthy and balanced lifestyle by controlling diet, physical activity, and timely medicine intake by knowing real-time blood glucose levels.